BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3128443)

  • 1. [Effect of 2 N-substituted aminotetralin derivatives with antihypertensive action on the monoamine oxidase activity of brain and liver preparations].
    Bogoslovova T; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1987; 26(4):40-4. PubMed ID: 3128443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of an aminotetralin derivative with pressor action on the monoamine oxidase activity of the brain and liver of rats].
    Bogoslovova T; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1987; 26(4):37-9. PubMed ID: 3446487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
    Mutafova-Iambolieva V; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1985; 24(1):8-12. PubMed ID: 2992908
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of monocrotophos on mono amine oxidase activity in albino rats.
    Swamy KV; Srinivas T; Mohan PM
    Biochem Int; 1991 Jul; 24(4):785-92. PubMed ID: 1799376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].
    Palm D; Magnus U; Grobecker H; Jonsson J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):281-300. PubMed ID: 4233003
    [No Abstract]   [Full Text] [Related]  

  • 7. Indirect central 5-hydroxytryptaminergic actions of methoxy substituted 2-aminotetralin derivatives.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Lindberg P; Wikström H; Svensson K; Hjorth S; Carlsson A
    Acta Pharm Suec; 1986; 23(2):77-90. PubMed ID: 3739739
    [No Abstract]   [Full Text] [Related]  

  • 8. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heavy metal salts on rat brain and liver monoamine oxidase activity.
    Kadiiska M; Stancheva S; Stoytchev Ts
    Acta Physiol Pharmacol Bulg; 1985; 11(4):27-32. PubMed ID: 3835805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ethanolic extract from root tuber of Polygonum multiflorum Thunb. on liver and brain monoamine oxidase in senescence-accelerated mice in vivo].
    Yang X
    Zhongguo Zhong Yao Za Zhi; 1996 Jan; 21(1):48-9, inside back cover. PubMed ID: 8703355
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.
    Cannon JG; Lee T; Goldman HD
    J Med Chem; 1977 Sep; 20(9):1111-6. PubMed ID: 562941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histocytochemical findings on in vitro and in vivo inhibition of monoamine oxidases].
    Couteaux R; Bouchaud C; Gautron J
    Actual Pharmacol (Paris); 1965; 18():33-68. PubMed ID: 5335795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in rat liver and brain monoamine oxidase activity after acute treatment with some heavy metal salts.
    Yanev S; Grahovska T; Kadiiska M; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1984; 10(3):36-45. PubMed ID: 6528814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
    Hoffmann IS; Naylor RJ; Cubeddu LX
    J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in rats.
    Fuller RW; Perry KW; Baker JC; Molloy BB
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):141-53. PubMed ID: 4455127
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitroglycerin (glyceryl trinitrate) as a monoamine oxidase inhibitor.
    Ogawa K; Gudbjarnason S; Bing RJ
    J Pharmacol Exp Ther; 1967 Mar; 155(3):449-55. PubMed ID: 4960617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.